Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-137410
Filing Date
2020-12-18
Accepted
2020-12-18 16:05:11
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2038581d1_form3.html 3  
1 FORM 3 tm2038581d1_form3.xml 3 2292
  Complete submission text file 0001104659-20-137410.txt   3780
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Xu Weihao (Reporting) CIK: 0001835368 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-20713 | Film No.: 201400641